These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 36341437)

  • 21. Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma.
    Zhang L; Xu J; Chu X; Zhang H; Yao X; Zhang J; Guo Y
    BMC Bioinformatics; 2022 Nov; 23(1):485. PubMed ID: 36384423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel Cuprotosis-related signature predicts the prognosis and selects personal treatments for melanoma based on bioinformatics analysis.
    Hu B; Hounye AH; Wang Z; Qi M; Zhang J
    Front Oncol; 2023; 13():1108128. PubMed ID: 36824136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a prognostic model using cuproptosis-related genes in uveal melanoma.
    Chen Y; Chen X; Wang X
    Front Cell Dev Biol; 2022; 10():973073. PubMed ID: 36111345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma.
    Tian XM; Xiang B; Yu YH; Li Q; Zhang ZX; Zhanghuang C; Jin LM; Wang JK; Mi T; Chen ML; Liu F; Wei GH
    Front Immunol; 2022; 13():999849. PubMed ID: 36211401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of cuproptosis in gastric cancer and relationship with clinical and drug reactions.
    Chen G; Luo D; Qi X; Li D; Zheng J; Luo Y; Zhang C; Ren Q; Lu Y; Chan YT; Chen B; Wu J; Wang N; Feng Y
    Front Cell Dev Biol; 2023; 11():1172895. PubMed ID: 37351275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative analysis of cuproptosis-associated genes for predicting immunotherapy response in single-cell and multi-cohort studies.
    Li H; Wang Y; Li G; Xiong J; Qin L; Wen Q; Yue C
    J Gene Med; 2024 Jan; 26(1):e3600. PubMed ID: 37776237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancer.
    Yang L; Tang Y; Zhang Y; Wang Y; Jiang P; Liu F; Feng N
    Sci Rep; 2024 Apr; 14(1):9570. PubMed ID: 38671021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC.
    Wang Y; Zhang Y; Wang L; Zhang N; Xu W; Zhou J; Zhao Y; Zhu W; Zhang T; Wang L
    Hepatol Int; 2022 Dec; 16(6):1435-1447. PubMed ID: 36065073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma.
    Chen Y; Zou X; Ma M; Liu Y; Wang R; Dai Z; Tashiheng Y; Yan Y; Yu X; Wang X; Liu C; Lin X; Cheng H
    Curr Oncol; 2023 Jan; 30(2):1648-1662. PubMed ID: 36826087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas.
    Huang H; Lv Z; Yang L; Zhang X; Deng Y; Huang Z; Bi H; Sun X; Zhang M; Hu D; Liang H; Hu F
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11499-11515. PubMed ID: 37392200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Significance of Cuproptosis-Related Gene Signatures in Breast Cancer Based on Transcriptomic Data Analysis.
    Zhou Z; Deng J; Pan T; Zhu Z; Zhou X; Lv C; Li H; Peng W; Lin B; Cai C; Wang H; Cai Y; Wei F; Zhou G
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of cuproptosis-related subtypes and characterization of the tumor microenvironment landscape in head and neck squamous cell carcinoma.
    Huang J; Xu Z; Yuan Z; Cheng L; Zhou C; Shen Y
    J Clin Lab Anal; 2022 Sep; 36(9):e24638. PubMed ID: 36082469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma.
    Liu X; Sun B; Yao Y; Lai L; Wang X; Xiong J; Zhang X; Jiang J
    Front Immunol; 2022; 13():996308. PubMed ID: 36275743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma.
    Wu Z; Li W; Zhu H; Li X; Zhou Y; Chen Q; Huang H; Zhang W; Jiang X; Ren C
    Front Genet; 2023; 14():1124439. PubMed ID: 36936439
    [No Abstract]   [Full Text] [Related]  

  • 35. Prediction model of clinical prognosis and immunotherapy efficacy of gastric cancer based on level of expression of cuproptosis-related genes.
    Zhao B; Wu W; Liang L; Cai X; Chen Y; Tang W
    Heliyon; 2023 Aug; 9(8):e19035. PubMed ID: 37636385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer.
    Xu L; Wang S; Zhang D; Wu Y; Shan J; Zhu H; Wang C; Wang Q
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16511-16523. PubMed ID: 37712959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation the role of cuproptosis-related genes in the pathogenesis, diagnosis and molecular subtypes identification of atherosclerosis.
    Wang M; Cheng L; Xiang Q; Gao Z; Ding Y; Xie H; Chen X; Yu P; Shen L
    Heliyon; 2023 Oct; 9(10):e21158. PubMed ID: 37928399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer.
    Du Y; Jiang W; Hou S; Chen Z; Zhou W
    Biomed Res Int; 2023; 2023():3419401. PubMed ID: 36714025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLC.
    Tang Y; Wang T; Li Q; Shi J
    Cancer Cell Int; 2024 Feb; 24(1):68. PubMed ID: 38341588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.
    Wang F; Lin H; Su Q; Li C
    World J Surg Oncol; 2022 Sep; 20(1):275. PubMed ID: 36050740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.